A low-toxicity uranyl-selective-binding linear pentapeptide sequence as a potential uranium decorporation agent

This is the authors' abstract. We don't add key points for this paper.

uranyl decorporation assays reveal that PP-B has a much lower toxicity and a much higher decorporation efficiency than that of the clinically approved DTPA. These findings render PP-B a promising candidate for utilization as a novel decorporation agent.